Here are the 424B prospectus supplements from HIVE Digital Technologies Ltd. (HIVE) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow HIVE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HIVE filings page.
HIVE Digital Technologies Ltd. has launched an at-the-market offering of up to $300,000,000 of common shares, to be sold from time to time through a syndicate of U.S. and Canadian agents. The shares will be issued at prevailing market prices on Nasdaq, the TSXV and other existing trading markets, with the company paying up to 3% of the gross sales price as agents' compensation. As of November 24, 2025, HIVE had 237,966,998 common shares outstanding, so any sales under this program would add to that base over time. The company plans to use net proceeds for general corporate and working capital needs, repaying debt, acquiring cryptocurrency mining equipment, and expanding its high-performance computing facilities and network.